All single peptides A to Z30 peptides, with a chart for each vial size
All blendsA blend is two or more peptides mixed in one vial.
All stacksA stack is two separate vials used together. Each page gives both draws.
All guidesEvery tool runs in your browser. Nothing you type is sent anywhere.
6 peptides are filed under longevity. SS-31 (elamipretide) has an approved product in the US, so its dose comes from a label. The other 5 have no approved label. Each page says whether its doses come from human trials or are only a reported range.
Peptides 6
Approved in the US 1
Authorized in Canada 0
Checked 10 Oct 2026| Peptide | Where the doses come from | How often | US | Canada |
|---|---|---|---|---|
| MOTS-c | Reported range, not a label dose | Once or twice weekly | Not approved | Not authorized |
| Epitalon | Reported range, not a label dose | Once daily | Not approved | Not authorized |
| NAD+ | Reported range, not a label dose | 1 to 3 times weekly | Not approved | Not authorized |
| SS-31 (elamipretide) | Reported range, not a label dose | Daily or twice weekly | Approved for one use | Not authorized |
| Cardiogen | Reported range, not a label dose | Once daily | Not approved | Not authorized |
| Livagen | Reported range, not a label dose | Once daily | Not approved | Not authorized |
US Not approved Canada Not authorized
The range reported for MOTS-c is 5 to 10 mg a week. No published study has given MOTS-c to people, so that range is untested. The research on giving it comes from mice and cells. It is not approved in the US or Canada, and WADA lists it as prohibited.
US Not approved Canada Not authorized
The range reported for Epitalon is 1 to 10 mg a day in short courses. The only human doses on record are far smaller and by other routes: 5 mcg injected beside the eye, and 0.5 mg a day under the tongue. It is not approved in the US or Canada.
US Not approved Canada Not authorized
The range reported for injected NAD+ is 25 to 100 mg, one to three times a week. Every human study gave NAD+ into a vein, at doses from 10 mg a day to 750 mg per infusion. No study of injecting it under the skin was found. There is no approved NAD+ drug.
US Approved for one use Canada Not authorized
The range reported for SS-31 is 1 to 10 mg, daily or twice a week. The approved product, Forzinity, is labelled at 40 mg under the skin once a day for Barth syndrome, a rare disease. Trials in other conditions did not meet their main goals. It is not authorized in Canada.
US Not approved Canada Not authorized
No published study has given Cardiogen to people, so there is no human dose. The 0.5 to 2 mg a day for 10 to 20 days that people report comes from sellers and users. The research is in rat tissue and rats. It is not approved in the US or Canada.
US Not approved Canada Not authorized
No published study has given Livagen to people, so there is no human dose. The 2 to 5 mg a day for 10 to 20 days that people report comes from sellers and users. The research is in cultured cells and rats. It is not approved in the US or Canada.
Weight loss and metabolicHealing and recoveryGrowth hormoneBrain and focusSkin and hairHormonal and sexual healthImmuneBlendsAll dosages A to Z
DosageFacts is an information site. It is not medical advice. Talk to a licensed professional before using any medication.